Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs.

by Melissa C Paoloni, Christina Mazcko, Elizabeth Fox, Timothy Fan, Susan Lana, William Kisseberth, David M Vail, Kaylee Nuckolls, Tanasa Osborne, Samuel Yalkowsy, Daniel Gustafson, Yunkai Yu, Liang Cao, Chand Khanna
Published 2010-06-01

Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma.

by Melissa Paoloni, Christina Mazcko, Kimberly Selting, Susan Lana, Lisa Barber, Jeffrey Phillips, Katherine Skorupski, David Vail, Heather Wilson, Barbara Biller, Anne Avery, Matti Kiupel, Amy LeBlanc, Anna Bernhardt, Beatrice Brunkhorst, Robert Tighe, Chand Khanna
Published 2015-01-01

Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.

by Melissa Paoloni, Craig Webb, Christina Mazcko, David Cherba, William Hendricks, Susan Lana, E J Ehrhart, Brad Charles, Heather Fehling, Leena Kumar, David Vail, Michael Henson, Michael Childress, Barbara Kitchell, Christopher Kingsley, Seungchan Kim, Mark Neff, Barbara Davis, Chand Khanna, Jeffrey Trent
Published 2014-01-01

A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model.

by Corey Saba, Melissa Paoloni, Christina Mazcko, William Kisseberth, Jenna H Burton, Annette Smith, Heather Wilson-Robles, Sara Allstadt, David Vail, Carolyn Henry, Susan Lana, E J Ehrhart, Brad Charles, Michael Kent, Jessica Lawrence, Kristine Burgess, Antonella Borgatti, Steve Suter, Paul Woods, Ira Gordon, Patricia Vrignaud, Chand Khanna, Amy K LeBlanc
Published 2016-01-01